Pulmonary Function Test Interpretation: A Step-by-Step Guide

Gas exchange is the second process in respiration, involving oxygen moving from alveoli to blood and carbon dioxide moving from blood to alveoli through simple diffusion without energy. The pulmonary membrane consists of six layers with thickness of 0.2-0.6 micrometers and surface area of 70 square meters. Five factors affect gas diffusion: partial pressure gradient (directly proportional), surface area (directly proportional), membrane thickness (inversely proportional), gas solubility (directly proportional), and molecular weight (inversely proportional). At sea level, atmospheric pressure is 760 mmHg, with alveolar oxygen partial pressure at 100 mmHg and carbon dioxide at 40 mmHg.

Alveoli are the primary site of gas exchange, with tissues as secondary site. Gas exchange occurs by simple diffusion along concentration gradients without energy. Three factors affect diffusion rate: (1) Pressure gradient - main factor; (2) Solubility - CO2 is 20-25 times more soluble than O2; (3) Membrane thickness - respiratory membrane is less than 1 mm thick. Gas exchange occurs along gradients: O2 from alveoli (104 mmHg) to blood (40 mmHg) to tissues (40 mmHg); CO2 from tissues (45 mmHg) to blood (40 mmHg) to alveoli (40 mmHg).

Fick's Law states that gas flux across the alveolar-capillary membrane equals diffusing capacity multiplied by the pressure gradient, where diffusing capacity depends on membrane surface area, thickness, gas solubility, and molecular weight; thus, diffusion is enhanced by larger surface areas, thinner membranes, more soluble gases, lighter molecular weights, and greater pressure gradients, explaining why conditions like emphysema (reduced surface area) and pulmonary fibrosis (increased thickness) impair oxygen transfer.

Gas exchange occurs at two sites: alveolar-capillary interface and tissue-capillary interface. Three factors affect diffusion: partial pressure gradient (gases move from high to low pressure), solubility (CO2 is 20-25 times more soluble than O2, diffusing faster), and membrane thickness (less than 1 mm, consisting of alveolar epithelium, basement membrane, and capillary endothelium). The thin membrane and high CO2 solubility ensure efficient gas exchange. Oxygen diffuses from alveoli (P O2 ~100 mmHg) to blood (P O2 ~40 mmHg), while CO2 diffuses from tissues to blood.

Four key factors determine the efficiency of gas exchange in the lungs: (1) Partial pressure differences drive gas movement; without sufficient gradients, exchange is inefficient. (2) Distance between alveoli and capillaries affects diffusion rate—increased distance (as in pulmonary edema) reduces efficiency. (3) Gas solubility determines how easily gases cross membranes; CO2 is highly soluble and diffuses readily, while O2 is less soluble. (4) Surface area of alveoli provides the physical space for gas exchange to occur. These principles explain why certain clinical conditions impair oxygen and carbon dioxide transfer between air and blood.

Breathing mechanics follow Boyle's Law (P ∝ 1/V). During inspiration, diaphragm and external intercostal contraction increases thoracic volume, decreasing intrapleural pressure below atmospheric pressure, causing air inflow. During passive expiration, elastic recoil of lungs and chest wall decreases thoracic volume, increasing pressure and forcing air out. Gravity creates vertical pressure gradients, with most negative pressure at lung apex and least at base, affecting regional ventilation distribution. Active expiration involves abdominal muscle contraction increasing intra-abdominal pressure, pushing diaphragm upward and further decreasing thoracic volume. This coordinated mechanical system enables efficient gas exchange throughout the respiratory cycle.

Air moves through bulk flow driven by pressure gradients from high to low pressure. Boyle's Law states pressure and volume are inversely related (P1V1 = P2V2). During inspiration, thoracic cavity expansion decreases pressure below atmospheric levels, drawing air in. During expiration, thoracic cavity contraction increases pressure above atmospheric levels, pushing air out. This pressure-volume relationship is fundamental to all breathing movements and explains how mechanical changes drive airflow.

This section explains the detailed mechanism of breathing and the fundamental relationship between volume and pressure. During inspiration, the intercostal muscles contract, causing the ribs to move upward and outward, while the diaphragm contracts and moves downward. These movements increase thoracic cavity volume, decreasing pressure and causing air to flow in. During expiration, the diaphragm relaxes and moves upward, and the intercostal muscles relax, allowing the ribs to move downward and inward. These movements decrease thoracic cavity volume, increasing pressure and forcing air out. The relationship between volume and pressure is the fundamental principle underlying breathing mechanics.

Breathing relies on pressure-volume relationships. During inspiration, diaphragm contraction and intercostal muscle contraction increase thoracic volume, decreasing intrapulmonary pressure below atmospheric pressure, causing air inflow until pressures equalize. During expiration, muscle relaxation allows elastic recoil, decreasing thoracic volume and increasing intrapulmonary pressure above atmospheric pressure, forcing air out until pressures equalize. This passive process normally requires no muscular effort.

This comprehensive guide covers major respiratory diseases including asthma, COPD, and pulmonary fibrosis. Asthma is fundamentally a problem of the respiratory airways, characterized by difficulty exhaling rather than inhaling, with risk factors including viral infections in children, genetic predisposition to allergies, and occupational diseases. The most common symptom is wheezing (piro), a whistling sound from complex airway structures. COPD involves chronic, progressive airway obstruction that worsens with each respiratory infection and causes irreversible lung function loss. Pulmonary fibrosis involves lung tissue stiffening, reducing both exhalation and inhalation capacity. Environmental factors are crucial: indoor air pollution is more significant than outdoor pollution because people spend 80% of their time indoors. Anti-inflammatory medications are essential in respiratory disease management, with corticosteroids treating acute crises and non-steroidal anti-inflammatories potentially causing bronchospasm in allergic individuals. Smoking is a major risk factor despite temporary benefits. Asthma diagnosis involves three essential components: clinical history, response to treatment, and respiratory function testing. Treatment focuses on managing underlying inflammation with anti-inflammatory medications and improving quality of life with bronchodilators. Asthma does not prevent athletic participation; many elite athletes including Olympic medalists have asthma and lead successful lives. Asthma is a genetic trait that individuals must manage throughout life, not a curable disease. Lifestyle management includes regular exercise focusing on endurance, anti-inflammatory dietary measures, and stress reduction. New treatments including biologic therapies and AI-driven diagnostic tools are advancing respiratory disease management, though prevention remains fundamental.

This section introduces the three major respiratory conditions: asthma, COPD, and pulmonary fibrosis. The speaker shares personal experience of confusion during medical training when all three conditions were treated identically with the same medications (budesonide and albuterol). The key distinction is that obstructive diseases (asthma, COPD) involve airway problems, while restrictive diseases (fibrosis) involve interstitial problems. Bronchodilators only work for obstructive diseases. The prevalence in Peru is: asthma 20-25%, COPD 6-7%, and fibrosis approximately 1%, making asthma the most common condition encountered in clinical practice.

Common respiratory disorders include common cold (rhinoviruses, adenoviruses, coronaviruses, lasting one week), influenza (influenza A and B viruses, sudden onset with high fever, lasting 1-2 weeks), pharyngitis (viral or bacterial infection of pharynx), tonsillitis (inflammation of tonsils), and laryngitis (inflammation of larynx). Pneumonia is a lower respiratory tract infection causing alveolar inflammation, with types including lobar, bronchopneumonia, and interstitial pneumonia. Tuberculosis is caused by Mycobacterium tuberculosis, an acid-fast bacillus that is aerobic, spreading through airborne droplets. Asthma is a chronic inflammatory disease of the airways characterized by reversible airway obstruction, with triggers including allergens, respiratory infections, exercise, and pollutants. COPD is a chronic inflammatory disease characterized by persistent airflow limitation, including chronic bronchitis (productive cough for at least 3 months per year for 2 consecutive years) and emphysema (destruction of alveolar walls). Pleural disorders include pleuritis (inflammation of pleural membranes), pneumothorax (air accumulation in pleural cavity causing lung collapse), and atelectasis (lung collapse from airway obstruction, compression, or contraction).

Asthma is a chronic inflammatory airway disorder with wheezing, breathlessness, chest tightness, and coughing. Etiological factors include allergies, air pollution, respiratory infections, stress, drugs, occupational exposures, and GERD. Pathophysiology involves immune activation, mast cell histamine release, cellular infiltration, swelling, and airway remodeling causing obstruction. Clinical manifestations vary by severity: mild shows wheezing and coughing; moderate includes respiratory distress and barrel chest; severe presents with absent breath sounds. Diagnostic evaluation includes pulmonary function tests, IgE levels, ABG analysis, and chest X-ray. Management includes environmental trigger avoidance, daily controller medications, oxygen therapy, chest physiotherapy, and ventilator support. COPD is characterized by irreversible air flow obstruction with progressive inflammation from noxious particles. It consists of chronic bronchitis (mucus hypersecretion lasting 3+ months) and emphysema (permanent alveolar distension with septal destruction). Causes include smoking, occupational dust, air pollution, respiratory infections, genetic factors, and aging. Pulmonary hypertension develops from chronic hypoxia causing vasoconstriction.

This comprehensive lecture covers major respiratory system disorders and their differentiation for nursing practice. Asthma presents with wheezing, dyspnea, chest tightness, and allergic triggers, and is reversible. COPD presents with smoking history, chronic cough, progressive dyspnea, and barrel chest, and is irreversible and progressive. Pneumonia presents with cough, fever, pleuritic chest pain, dyspnea, crackles, and consolidation on X-ray. Pulmonary embolism presents with sudden chest pain, sudden dyspnea, tachycardia, and hypoxia. Pneumothorax presents with hyperresonance on percussion. Tuberculosis presents with persistent cough, night sweats, fever, weight loss, and positive tuberculin test. Acute bronchitis presents with productive or nonproductive cough, viral history, and no fever. Pulmonary fibrosis presents with progressive dyspnea, dry cough, environmental exposures, fine crackles, and restrictive pattern on pulmonary function tests. Understanding pathophysiology is fundamental for diagnosis: asthma involves inflammation and narrowing of airways; COPD involves progressive and irreversible airflow limitation; pneumonia involves infection causing consolidation; pulmonary embolism involves thrombus obstruction; tuberculosis involves Mycobacterium tuberculosis infection; acute bronchitis involves viral inflammation; pulmonary fibrosis involves scarring and thickening of lung tissue. Clinical decision-making involves identifying key symptoms that point to specific conditions, and guideline-based management of asthma involves assessing adherence, reassessing asthma phenotype, reviewing trigger management, and adjusting medications. The ADPIE process (Assessment, Diagnosis, Planning, Implementation, Evaluation) is fundamental to respiratory care.